Avacopan for treating anti-neutrophil cytoplasmic antibody-associated vasculitis [ID1178]
Discontinued
Reference number: GID-TA10199
The Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of avacopan for inducing remission in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Please note that following on from advice received from the company, NICE has decided to suspend this appraisal from its current work programme.
As this appraisal has been referred, NICE will continue to monitor any developments and will provide an update if and when the situation changes.